Pathogenesis and progression of proteinuria

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 48-56

  Thomas, Merlin C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BOWMAN CAPSULE; DISEASE COURSE; GLOMERULUS; HEMODYNAMICS; HUMAN; KIDNEY PROXIMAL TUBULE; METABOLISM; PHYSIOLOGY; PODOCYTE; PROTEINURIA; VASCULAR ENDOTHELIUM;

ANIMALS; BOWMAN CAPSULE; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; PODOCYTES; PROTEINURIA;

EID: 84925935926     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324943     Document Type: Article

References (25)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310:356-360. (Pubitemid 14179541)
2. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, et al: Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 2005;9:iii-vi, xiii-163.
3. Abbate M, Zoja C, Remuzzi G: How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974-2984. (Pubitemid 44707757)
4. Salmon AH, Neal CR, Harper SJ: New aspects of glomerular filtration barrier structure and function: Five layers (at least) not three. Curr Opin Nephrol Hypertens 2009; 18:197-205.
5. Heathcote KL, Wilson MP, Quest DW, Wilson TW: Prevalence and duration of exercise induced albuminuria in healthy people. Clin Invest Med 2009;32:E261-E265.
6. Romanelli G, Giustina A, Bossoni S, Caldonazzo A, Cimino A, Cravarezza P, et al: Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes 1990;39: 1333-1338. (Pubitemid 20372220)
7. Jarad G, Miner JH: Update on the glomerular filtration barrier. Curr Opin Nephrol Hypertens 2009;18:226-232.
8. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW: Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007;18:2885-2893. (Pubitemid 350058395)
9. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, et al: Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006;55: 1127-1132. (Pubitemid 44100191)
10. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N: Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010;53:2056-2065.
11. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P: Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 2000;26(suppl 4):8-14. (Pubitemid 30618351)
12. Harvey SJ, Jarad G, Cunningham J, Rops AL, van der Vlag J, Berden JH, et al: Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 2007;171: 139-152. (Pubitemid 47339234)
13. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008;4:39-45. (Pubitemid 351210971)
14. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131-247.
15. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003;285: F40-F48. (Pubitemid 36818460)
16. Gagliardini E, Conti S, Benigni A, Remuzzi G, Remuzzi A: Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 2010;21:2081-2089.
17. Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, et al: Modulation of nephrin in the diabetic kidney: Association with systemic hypertension and increasing albuminuria. J Hypertens 2002;20:985-992. (Pubitemid 34913680)
18. Eyre J, Ioannou K, Grubb BD, Saleem MA, Mathieson PW, Brunskill NJ, et al: Statinsensitive endocytosis of albumin by glomerular podocytes. Am J Physiol Renal Physiol 2007;292:F674-F681. (Pubitemid 46220536)
19. Peti-Peterdi J, Sipos A: A high-powered view of the filtration barrier. J Am Soc Nephrol 2010;21:1835-1841.
20. Thomas MC, Burns WC, Cooper ME: Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 2005;12: 177-186. (Pubitemid 40489000)
21. Thomson SC, Vallon V, Blantz RC : Kidney function in early diabetes: The tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004;286: F8-F15. (Pubitemid 38045037)
22. Russo LM, Sandoval RM, Campos SB, Molitoris BA, Comper WD, Brown D: Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol 2009;20:489-494.
23. Thrailkill KM, Nimmo T, Bunn RC, Cockrell GE, Moreau CS, Mackintosh S, et al: Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin. Diabetes Care 2009;32:1266-1268.
24. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000;49:1579-1584.
25. Herman-Edelstein M, Thomas M, Thallas-Bonke V, Saleem M, Cooper ME, Kantharidis P: De-differentiation of immortalised human podocytes in response to transforming growth factor ß -a model for diabetic podocytopathy. Diabetes (in press).